See also this year's filing and all EDGAR filings for this company.
PDF Report 0001349929_2015_Vyant_Bio_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.23018535141178878, 'aggregate_val': 48884000, 'exp_sum': 63501000, 'exp_to_value': {'IntangibleAssets': 12029000, 'AssetsNonCurrent': 14617000, 'AssetsCurrent': 28198000, 'PropertyPlantAndEquipment': 6069000, 'remainder_Assets': 2588000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.18769929916430603, 'aggregate_val': 47105130, 'exp_sum': 57989769, 'exp_to_value': {'IntangibleAssets': 2994135, 'AssetsNonCurrent': 10884639, 'AssetsCurrent': 31773898, 'PropertyPlantAndEquipment': 4446593, 'remainder_Assets': 7890504}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001349929')"} |
Graph
Absolute values for 0001349929, Vyant Bio Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 2,994,135 |
| 1 | AssetsNonCurrent | 10,884,639 |
| 2 | AssetsCurrent | 31,773,898 |
| 3 | PropertyPlantAndEquipment | 4,446,593 |
| 4 | remainder_Assets | -2,994,135 |
| 5 | LongTermLiabilities | 6,560,341 |
| 6 | LiabilitiesCurrent | 4,365,963 |
| 7 | remainder_Liabilities | 1,625,075 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 8,453,671 |
| 10 | GeneralAndAdministrativeExpense | 12,368,739 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 3,963,537 |
| 15 | ResearchAndDevelopmentExpense | 4,622,526 |
| 16 | remainder_Expenses | -2,350,185 |
| 17 | remainder_Revenues | 10,199,387 |
| 18 | remainder_NetIncome | 215,982 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 47,105,130 |
| 1 | Liabilities | 12,551,379 |
| 2 | Expenses | 27,058,288 |
| 3 | Revenues | 10,199,387 |
| 4 | StockholdersEquity | 34,553,751 |
| 5 | NetIncome | -16,642,919 |
| 6 | ComprehensiveNetIncome | -16,642,919 |
| 7 | BaseVar | 48,565,083 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.12 |
| 9 | EconomicCapitalRatio | 1.79 |